Why the study?
Does fetal echocardiography identify cardiac causes of in utero heart failure in fetuses with nonimmune hydrops?
Population
13 fetuses with nonimmune hydrops (22 to 39 weeks of gestation)
Design
Case_series
Authors
Loading...
May support fetal echocardiography in nonimmune hydrops evaluation; leaves open impact on outcomes in prospective cohorts.
Does fetal echocardiography identify cardiac causes of in utero heart failure in fetuses with nonimmune hydrops?
Fetal echocardiography is a useful diagnostic tool for identifying cardiovascular causes of nonimmune hydrops and can be used to monitor transplacental therapy.
Kleinman et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: